Shares of Global Blood Therapeutics Inc. GBT, +3.04% were up 34.4% in premarket trading on Thursday after Bloomberg reported that the company is "attracting takeover interest," citing people familiar with the matter. Global Blood Therapeutics markets a treatment for sickle-cell disease called Oxbryta, which generated $
Full Story >>
Vote
+25